177 related articles for article (PubMed ID: 14734452)
21. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.
Suzuki K; Fueyo J; Krasnykh V; Reynolds PN; Curiel DT; Alemany R
Clin Cancer Res; 2001 Jan; 7(1):120-6. PubMed ID: 11205899
[TBL] [Abstract][Full Text] [Related]
22. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
Tyler MA; Ulasov IV; Borovjagin A; Sonabend AM; Khramtsov A; Han Y; Dent P; Fisher PB; Curiel DT; Lesniak MS
Mol Cancer Ther; 2006 Sep; 5(9):2408-16. PubMed ID: 16985075
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
van der Poel HG; Molenaar B; van Beusechem VW; Haisma HJ; Rodriguez R; Curiel DT; Gerritsen WR
J Urol; 2002 Jul; 168(1):266-72. PubMed ID: 12050554
[TBL] [Abstract][Full Text] [Related]
24. Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model.
Cody JJ; Rivera AA; Lyons GR; Yang SW; Wang M; Ashley JW; Meleth S; Feng X; Siegal GP; Douglas JT
Lab Invest; 2013 Mar; 93(3):268-78. PubMed ID: 23358109
[TBL] [Abstract][Full Text] [Related]
25. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT
Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
Lee CT; Park KH; Yanagisawa K; Adachi Y; Ohm JE; Nadaf S; Dikov MM; Curiel DT; Carbone DP
Cancer Res; 2004 Sep; 64(18):6660-5. PubMed ID: 15374981
[TBL] [Abstract][Full Text] [Related]
27. Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
Lam JT; Kanerva A; Bauerschmitz GJ; Takayama K; Suzuki K; Yamamoto M; Bhoola SM; Liu B; Wang M; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
J Gene Med; 2004 Dec; 6(12):1333-42. PubMed ID: 15493039
[TBL] [Abstract][Full Text] [Related]
28. Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer.
Yamamoto M; Davydova J; Wang M; Siegal GP; Krasnykh V; Vickers SM; Curiel DT
Gastroenterology; 2003 Oct; 125(4):1203-18. PubMed ID: 14517802
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
[TBL] [Abstract][Full Text] [Related]
30. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts.
Fuxe J; Liu L; Malin S; Philipson L; Collins VP; Pettersson RF
Int J Cancer; 2003 Mar; 103(6):723-9. PubMed ID: 12516090
[TBL] [Abstract][Full Text] [Related]
31. In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.
Lee CT; Lee YJ; Kwon SY; Lee J; Kim KI; Park KH; Kang JH; Yoo CG; Kim YW; Han SK; Chung JK; Shim YS; Curiel DT; Carbone DP
Cancer Res; 2006 Jan; 66(1):372-7. PubMed ID: 16397251
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
33. Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.
Bauerschmitz GJ; Lam JT; Kanerva A; Suzuki K; Nettelbeck DM; Dmitriev I; Krasnykh V; Mikheeva GV; Barnes MN; Alvarez RD; Dall P; Alemany R; Curiel DT; Hemminki A
Cancer Res; 2002 Mar; 62(5):1266-70. PubMed ID: 11888888
[TBL] [Abstract][Full Text] [Related]
34. Differential role of alpha(v)beta(3) and alpha(v)beta(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses.
Majhen D; Nemet J; Richardson J; Gabrilovac J; Hajsig M; Osmak M; Eloit M; Ambriović-Ristov A
Virus Res; 2009 Jan; 139(1):64-73. PubMed ID: 19013487
[TBL] [Abstract][Full Text] [Related]
35. Ad5
Uusi-Kerttula H; Davies JA; Thompson JM; Wongthida P; Evgin L; Shim KG; Bradshaw A; Baker AT; Rizkallah PJ; Jones R; Hanna L; Hudson E; Vile RG; Chester JD; Parker AL
Clin Cancer Res; 2018 Sep; 24(17):4215-4224. PubMed ID: 29798908
[No Abstract] [Full Text] [Related]
36. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents.
González-Pastor R; Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Lu ZH; Goedegebuure SP; Podhajcer OL; Curiel DT
J Ovarian Res; 2019 Feb; 12(1):18. PubMed ID: 30767772
[TBL] [Abstract][Full Text] [Related]
37. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
38. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
Iguchi K; Sakurai F; Tomita K; Katayama K; Yamaguchi T; Kawabata K; Tagawa M; Kawabata M; Shirakawa T; Mizuguchi H
Cancer Gene Ther; 2012 Feb; 19(2):118-25. PubMed ID: 22076042
[TBL] [Abstract][Full Text] [Related]
39. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.
van Beusechem VW; Mastenbroek DC; van den Doel PB; Lamfers ML; Grill J; Würdinger T; Haisma HJ; Pinedo HM; Gerritsen WR
Gene Ther; 2003 Nov; 10(23):1982-91. PubMed ID: 14528322
[TBL] [Abstract][Full Text] [Related]
40. Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence.
Rebetz J; Na M; Su C; Holmqvist B; Edqvist A; Nyberg C; Widegren B; Salford LG; Sjögren HO; Arnberg N; Qian Q; Fan X
PLoS One; 2009 Dec; 4(12):e8484. PubMed ID: 20041185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
